Inactive Instrument

Analyst Reco. IMAX Corporation Toronto S.E.

Equities

IMX

CA45245E1097

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Barrington Raises Price Target on Imax to $25 From $24, Maintains Outperform Rating	Apr. 26	MT
B. Riley Securities Adjusts Imax's Price Target to $27 From $25, Keeps Buy Rating	Apr. 26	MT
B. Riley Securities Raises Imax's PT to $25 From $21 After Q4 2023 Results Exceed Estimates, Keeps Buy Rating	Feb. 28	MT
Rosenblatt Adjusts Imax's Price Target to $25 From $30, Keeps Buy Rating	Feb. 13	MT
Benchmark Cuts Imax's Price Target to $22 From $24, Keeps Buy Rating	Jan. 18	MT
Goldman Sachs Adjusts Imax Price Target to $13 From $15, Maintains Sell Rating	Jan. 11	MT
B. Riley Lowers Imax's PT to $21 From $27, Notes Near-Term Domestic Industry Box Office Concerns; Maintains Buy Rating	Jan. 02	MT
Benchmark Adjusts Price Target on Imax to $24 From $23, Keeps Buy Rating	23-10-09	MT
Rosenblatt Adjusts Price Target on Imax to $30 From $27, Maintains Buy Rating	23-07-27	MT
Benchmark Adjusts Price Target on Imax to $23 From $22, Maintains Buy Rating	23-05-02	MT
Roth MKM Adjusts Imax's Price Target to $26 From $24, Keeps Buy Rating	23-04-28	MT
Wells Fargo Adjusts Price Target on Imax to $25 From $22, Maintains Overweight Rating	23-04-28	MT
Rosenblatt Adjusts Price Target on Imax to $27 From $25, Maintains Buy Rating	23-04-28	MT
B. Riley Lifts Imax's Price Target to $27 From $26 After Higher-Than-Expected Q1 Results, Keeps Buy Rating	23-04-28	MT
Wedbush Lifts Imax's Price Target to $26 From $25 After 'Solid' Q1 Results, Keeps Outperform Rating	23-04-28	MT
Wedbush Raises Imax's Price Target to $25 From $22, Notes 'Strong' Trends; Keeps Outperform Rating	23-04-25	MT
Goldman Sachs Raises Price Target on Imax to $15 From $14, Maintains Sell Rating	23-04-21	MT
B. Riley Raises Imax's Price Target to $26 From $23 on Improved Optimism on Box Office Outlook Into 2024, Keeps Buy Rating	23-04-10	MT
Goldman Sachs Adjusts Price Target on Imax to $14 From $12, Maintains Sell Rating	23-02-28	MT
Barrington Raises Imax's Price Target to $22 From $20, Maintains Outperform Rating	23-02-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. IMAX Corporation Toronto S.E.

Equities

IMX

CA45245E1097

Analyst Reco.

Filters